English Site German Site
  • News & Events
  • About us
  • Careers
  • Support
  • EKF Partners
  • Contact
EKF Diagnostics, UK
  • Home
  • Hemoglobin Analysers
  • HbA1c Analysers
  • Glucose Analysers
  • Lactate Analysers
  • Clinical Chemistry
  • Pregnancy Testing
  • Investors

 

 

 

An error has occured

Please click here to go to the homepage.
  • News
  • Investor Announcements
Twitter Facebook Linkedin RSS
25 April 2012. Stanbio Laboratory to Transition HemoPoint® H2 Hemoglobin System to Alere Inc Stanbio Laboratory announced today that the sales, marketing and service functions in the United States for its popular point-of-care HemoPoint® H2 hemoglobin system has been transitioned to Alere, Inc. 25 April 2012. The majority of NHS spending on diabetes is avoidable The majority of NHS spending on diabetes is avoidable, says a report in the journal 20 April 2012. EKF Annual Report 2011 EKF Diagnostics' 2011 Annual Report is now available to download.
Update on the Disposal of International Brand Licensing AG Update on the Disposal of International Brand Licensing AG 27 March 2012. Disposal of International Brand Licensing AG EKF Diagnostics Holdings plc, the growing in-vitro diagnostics company, announces that it has sold its Swiss subsidiary, International Brand Licensing AG for a cash consideration of £50,000, payable over a 2 year period. 26 March 2012. Edit to Investors section The EKF Finance and Investors section has been updated.
STANBIO Laboratory, An EKF Diagnostics Company
Argutus Medical, An EKF Diagnostics Company
  • Terms
  • Privacy
  • Site Map
  • Remote Support
  • General Terms of Sale and Delivery
Website designed by atticusdigital